Supreme Court rulings end Japan Iressa litigation
This article was originally published in Scrip
Executive Summary
Japan's Supreme Court has rejected appeals from plaintiffs seeking redress for side-effects and deaths occurring during the use of AstraZeneca's lung cancer drug Iressa (gefitinib) and hoping to overturn earlier lower court rulings absolving the government of responsibility in the affair.